118 related articles for article (PubMed ID: 7907781)
1. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
Spinola M; Pedotti P; Dragani TA; Taioli E
Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
De Angelis PM; Clausen OP; Schjølberg A; Stokke T
Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
[TBL] [Abstract][Full Text] [Related]
4. 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer.
Purdie CA; Piris J; Bird CC; Wyllie AH
J Pathol; 1995 Mar; 175(3):297-302. PubMed ID: 7745498
[TBL] [Abstract][Full Text] [Related]
5. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
6. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
7. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.
Yamaguchi T; Toguchida J; Yamamuro T; Kotoura Y; Takada N; Kawaguchi N; Kaneko Y; Nakamura Y; Sasaki MS; Ishizaki K
Cancer Res; 1992 May; 52(9):2419-23. PubMed ID: 1568211
[TBL] [Abstract][Full Text] [Related]
8. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.
Choi SW; Lee KJ; Bae YA; Min KO; Kwon MS; Kim KM; Rhyu MG
Clin Cancer Res; 2002 Jul; 8(7):2311-22. PubMed ID: 12114436
[TBL] [Abstract][Full Text] [Related]
9. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
10. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
11. [S allele of the L-myc oncogene is associated with lung cancer metastases in patients from Moldova].
Chernitsa OI; Togo AV; Shutkin VA; Khanson KP; Imianitov EN
Vopr Onkol; 1998; 44(1):33-6. PubMed ID: 9578728
[TBL] [Abstract][Full Text] [Related]
12. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
Ozakyol A; Ozdemir M; Artan S
Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer.
Tomlinson I; Ilyas M; Johnson V; Davies A; Clark G; Talbot I; Bodmer W
J Pathol; 1998 Feb; 184(2):148-52. PubMed ID: 9602705
[TBL] [Abstract][Full Text] [Related]
14. [Association between H-ras and L-myc gene polymorphisms and susceptibility to colorectal cancer].
Ni Q; Zhang YJ; Zhang SC; Jin MJ; Ma XY; Yao KY; Li QL; Chen K
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):15-20. PubMed ID: 22490849
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
16. MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer.
Osian G; Procopciuc L; Vlad L
J Gastrointestin Liver Dis; 2007 Sep; 16(3):251-6. PubMed ID: 17925917
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
18. [Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage].
Wu GY; Wang XM; Keese M; Hasenberg T; Sturm JW
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1505-7. PubMed ID: 17349182
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Dimberg J; Hugander A; Löfgren S; Wågsäter D
Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
[TBL] [Abstract][Full Text] [Related]
20. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
